Free Trial
CVE:SCYB

Scythian Biosciences (SCYB) Stock Price, News & Analysis

C$3.49 -0.22 (-5.93%)
As of 07/25/2018

About Scythian Biosciences Stock (CVE:SCYB)

Key Stats

Today's Range
C$3.46
C$3.77
50-Day Range
C$3.49
C$3.49
52-Week Range
C$1.01
C$8.61
Volume
703,164 shs
Average Volume
231,491 shs
Market Capitalization
C$102.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SCYB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scythian Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SCYB Stock News Headlines

Scryb Inc. (SCYRF)
Schwab High Yield Bond ETF (SCYB)
Gold surges past $3,600 … but this has beat gold by 1,000x
Gold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real opportunity isn’t in coins or bullion. In every major gold rally of the past 50 years, there’s been another investment that has delivered dramatically higher returns.tc pixel
Scryb Inc SCYB
Scryb Inc. (SCYB.CN)
Ventrus Biosciences (VTUS) Stock Surges Today
Canadian Jobs to be Presented Next Friday
See More Headlines

SCYB Stock Analysis - Frequently Asked Questions

Scythian Biosciences' stock was trading at C$3.49 at the beginning of 2025. Since then, SCYB shares have increased by 0.0% and is now trading at C$3.49.

Shares of SCYB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scythian Biosciences investors own include DraftKings (DKNG), Lithium South Development Co. (NGZ.V) (NGZ), Organigram (OGI), Scythian Biosciences (SCCYF), SOL Global Investments (SOLCF), CanniMed Therapeutics (CMED) and Compugen (CGEN).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:SCYB
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
29,334,000
Free Float
N/A
Market Cap
C$102.38 million
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (CVE:SCYB) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners